1Department of Surgery, Soonchunhyang University Medicine School 2Clinical Pathology, Soonchunhyang University Medicine School
Corresponding Author:
Yong Jin Kim ,Tel: +82-2-709-9479, Fax: +82-2-795-1687, Email: yjkim@hosp.sch.ac.kr
Received: April 28, 2008; Accepted: May 19, 2008.
Share :
ABSTRACT
Purpose: Although the TNM stage is the most important prognostic factor for gastric cancer, there is a need for new prognostic
factors, because the prognosis varies among patients of the same stage. The aim of this study was to clarify the prognostic significance
of E-cadherin, -catenin, c-erb B2, and p53 in patients with gastric cancers.
Materials and Methods: Loss of membranous expression of E-cadherin & -catenin, abnormal c-erb B2 membranous expression,
and overexpression of p53 were investigated immunohistochemically using 96 cases of paraffin embedded tissue of gastric carcinomas
at Soonchunhyang University in 2002. These were correlated with the clinicopathological parameters such as age, depth
of invasion, lymph node metastasis, histology, Lauren classification, and survival were analyzed retrospectively. There were 61 males
and 35 females (1.7:1) with a mean age of 57.5 years (range:36~73 years).
Results: The percentage of abnormal expression of E-cadherin, -catenin, c-erbB-2, and p53 were 76/96 (79.2%), 62/96
(64.6%), 48/96 (50%), and 45/96 (46.9%), respectively. Abnormal expression of E-cadherin occurred more frequently in
serosa-invasive than serosa-noninvasive groups (p<0.05). In all cases with preserved expression of E-cadherin, recurrence was not
occured regardless of the stage. Abnormal expression of -catenin, c-erb B2, and p53 were not related with clnicopathological parameters.
The prognosis was associated with lymph node metastasis (p=0.0087) and serosa invasion (p=0.0277) in an univariate analysis.
Lymph node metastasis is an independent prognostic factor in patients with gastric cancers(p=0.0047).
Conclusion: Although this study was performed with small number of cases and shortage of the follow-up time, E-cadherin showed
the possibility as one of prognostic factors in gastric cancer.